Fraunhofer-Gesellschaft

These days, even a “simple” infection can become a deadly threat again. Bacteria keep developing new resistances to antibiotics, presenting the international medical community with a significant problem. There is a desperate need for new medications. The biggest hurdle in developing these new medications is getting them from the laboratory into clinical trials, bridging the gap from the discovery of new agents to their development by the pharmaceutical industry into potential medications.

In the project iCAIR® (International Consortium for Anti-Infective Research), researchers from Fraunhofer ITEM, the Hannover Medical School, Helmholtz Centre for Infection Research in Braunschweig, and Griffith University's Institute for Glycomics in Gold Coast, Australia, have teamed up to close this gap.